These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18650485)

  • 1. Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury.
    Prakash J; de Borst MH; Lacombe M; Opdam F; Klok PA; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
    J Am Soc Nephrol; 2008 Nov; 19(11):2086-97. PubMed ID: 18650485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
    Poosti F; Yazdani S; Dolman ME; Kok RJ; Chen C; Ding G; Lacombe M; Prakash J; van den Born J; Hillebrands JL; van Goor H; de Borst MH
    Eur J Pharmacol; 2012 Nov; 694(1-3):111-9. PubMed ID: 22964464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis.
    Prakash J; Sandovici M; Saluja V; Lacombe M; Schaapveld RQ; de Borst MH; van Goor H; Henning RH; Proost JH; Moolenaar F; Këri G; Meijer DK; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):8-19. PubMed ID: 16807361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ρ-Kinase inhibition reduces early microvascular leukocyte accumulation in the rat kidney following ischemia-reperfusion injury: roles of nitric oxide and blood flow.
    Versteilen AM; Blaauw N; Di Maggio F; Groeneveld AB; Sipkema P; Musters RJ; Tangelder GJ
    Nephron Exp Nephrol; 2011; 118(4):e79-86. PubMed ID: 21311198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion.
    Wei J; Li Z; Ma C; Zhan F; Wu W; Han H; Huang Y; Li W; Chen D; Peng Y
    Cell Biol Int; 2013 Jul; 37(7):725-30. PubMed ID: 23456826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
    van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
    Prakash J; de Borst MH; van Loenen-Weemaes AM; Lacombe M; Opdam F; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
    Pharm Res; 2008 Oct; 25(10):2427-39. PubMed ID: 18183478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-27632, a Rho-kinase inhibitor, attenuates myocardial ischemia-reperfusion injury in rats.
    Dong LY; Qiu XX; Zhuang Y; Xue S
    Int J Mol Med; 2019 Apr; 43(4):1911-1919. PubMed ID: 30816436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
    Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
    Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
    Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
    Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
    van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
    Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
    de Borst MH; Prakash J; Sandovici M; Klok PA; Hamming I; Kok RJ; Navis G; van Goor H
    J Pharmacol Exp Ther; 2009 Dec; 331(3):896-905. PubMed ID: 19717791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats.
    Kuroda S; Tashiro H; Kimura Y; Hirata K; Tsutada M; Mikuriya Y; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    Liver Transpl; 2015 Jan; 21(1):123-31. PubMed ID: 25307969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
    J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK inhibitor Y‑27632 protects rats against cerebral ischemia/reperfusion‑induced behavioral deficits and hippocampal damage.
    Li L; Liu B
    Mol Med Rep; 2019 Oct; 20(4):3395-3405. PubMed ID: 31432130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of rho-kinase pathway in contractile activity of rabbit RPE cells in vivo and in vitro.
    Zheng Y; Bando H; Ikuno Y; Oshima Y; Sawa M; Ohji M; Tano Y
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):668-74. PubMed ID: 14744913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice.
    Furuichi K; Wada T; Iwata Y; Sakai N; Yoshimoto K; Kobayashi Ki K; Mukaida N; Matsushima K; Yokoyama H
    Nephrol Dial Transplant; 2002 Mar; 17(3):399-407. PubMed ID: 11865084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.
    Feitoza CQ; Gonçalves GM; Semedo P; Cenedeze MA; Pinheiro HS; Beraldo FC; dos Santos OF; Teixeira Vde P; dos Reis MA; Mazzali M; Pacheco-Silva A; Câmara NO
    Mol Med; 2008; 14(11-12):724-30. PubMed ID: 18769637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA/Rho kinase signaling regulates transforming growth factor-β1-induced chondrogenesis and actin organization of synovium-derived mesenchymal stem cells through interaction with the Smad pathway.
    Xu T; Wu M; Feng J; Lin X; Gu Z
    Int J Mol Med; 2012 Nov; 30(5):1119-25. PubMed ID: 22922645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.